Community-Acquired Pneumonia (CAP)

Definition

Community-acquired pneumonia (CAP) is defined as an acute infection of the lung parenchyma in a person who has acquired the infection in the community, as distinguished from a hospital or long-term care facility setting (1). The clinical diagnosis requires evidence of an acute lower respiratory tract illness along with new radiological infiltrates on a chest X-ray (1).

Epidemiology

In Malaysia, pneumonia represents a significant public health burden. In 2023, it was reported as the leading cause of death in the country (4). It stands as the second leading cause of overall mortality, responsible for 11.4% of all deaths, underscoring its clinical significance (1). CAP drives a substantial volume of healthcare utilization, with an estimated 20% of diagnosed patients requiring hospitalization. Of those admitted, approximately 1% will develop severe disease necessitating ICU admission (5). The condition disproportionately affects vulnerable groups, particularly older adults and individuals with chronic comorbidities (1).

Pathophysiology

The development of CAP results from a failure of the host's lung defense mechanisms to prevent microbial invasion (1). The most common route of infection is the microaspiration of oropharyngeal secretions, which introduces pathogens into the lower airways (1). The outcome depends on the interplay between the virulence of the microorganism and the integrity of the host's defenses, which include the cough reflex, the mucociliary escalator, and alveolar macrophages (1). Pathogens like Streptococcus pneumoniae possess virulence factors, such as a polysaccharide capsule, that help them evade these defenses (1). Other pathogens, like Mycoplasma pneumoniae or Influenza virus, damage the respiratory epithelium, impairing clearance mechanisms and creating a window for infection (1).

Clinical Presentation

The classic presentation of CAP involves an acute onset of respiratory and systemic symptoms.

Diagnostic Clues: A rusty-colored sputum is a classic, though not always present, sign associated with pneumococcal pneumonia (19).

Common Symptoms (>50%):

  • Cough, which may be productive of purulent (yellow/green) sputum (19)

  • Fever, often accompanied by chills and rigors (19)

  • Shortness of breath (dyspnoea) (19)

  • Pleuritic chest pain (sharp pain on inspiration) (19)

Less Common Symptoms (10-50%):

  • Profound fatigue and malaise (19)

  • Loss of appetite (19)

  • Headache (19)

  • Night sweats (19)

⚠️ Red Flag Signs & Symptoms:

  • New confusion or disorientation (the 'C' in the CURB-65 score) (8)

  • Respiratory rate ≥ 30 breaths/minute (the 'R' in the CURB-65 score) (8)

  • Hypotension (Systolic BP < 90 mmHg or Diastolic BP ≤ 60 mmHg) (the 'B' in the CURB-65 score) (8)

  • Central cyanosis, indicating severe hypoxemia (20)

  • Inability to speak in full sentences, a sign of significant respiratory distress (20)

Complications

Complications of CAP can be severe and are often what necessitate hospitalization and intensive care.

  • Respiratory: Acute respiratory failure (Type 1 or Type 2), parapneumonic effusion, empyema, and lung abscess (3, 82).

  • Cardiovascular: Septic shock, cardiac arrhythmias, and exacerbation of underlying heart failure (8, 38).

  • Systemic: Sepsis, acute kidney injury, and multi-organ dysfunction (8, 41).

Prognosis

The prognosis of CAP is directly linked to its severity, which is best assessed using the CURB-65 score. For patients with a score of 0-1 (mild CAP), the 30-day mortality risk is less than 3% (8). This risk climbs to 3-15% for a score of 2 (moderate CAP) and exceeds 15% for a score of 3 or more (severe CAP) (8). Key factors that worsen prognosis include advanced age, the presence of comorbidities, and the development of complications like sepsis or respiratory failure (1).

Differential Diagnosis

  • Acute Bronchitis. This is a primary differential due to the shared symptom of cough (27). However, acute bronchitis is less likely if the patient presents with high fever, systemic illness, and signs of consolidation on examination. The chest X-ray in bronchitis is characteristically clear of new infiltrates (27).

  • Pulmonary Embolism (PE). Consider PE in patients with a sudden onset of dyspnoea and pleuritic chest pain (33). It is less likely in the presence of a productive cough and high fever. A history lacking risk factors for venous thromboembolism (e.g., recent surgery, immobility, malignancy) also points away from PE (33).

  • Acute Heart Failure (AHF). This is a common mimic, especially in the elderly (38). AHF is more probable given a history of cardiac disease, orthopnoea, or paroxysmal nocturnal dyspnoea. Key distinguishing signs include a raised jugular venous pressure (JVP), an S3 gallop, and bilateral basal fine crackles on auscultation, in contrast to the focal, coarser crackles of pneumonia (38).

Investigations

Immediate & Bedside Tests

  • Pulse Oximetry: This is a mandatory "fifth vital sign" to rapidly detect hypoxemia (the rationale), a key marker of severity that requires immediate oxygen supplementation (the action) (2).

  • Arterial Blood Gas (ABG): Indicated for any patient with significant respiratory distress or hypoxemia (SpO2 <92%) to precisely measure oxygenation (PaO2) and acid-base status (the rationale), which is critical for identifying respiratory failure and guiding respiratory support (the action) (2).

Diagnostic Workup

  • First-Line Investigations: A Chest X-ray (CXR) is the essential first-line investigation. It is required to confirm the diagnosis by identifying new parenchymal infiltrates (the rationale) and to assess severity and detect complications (the action) (1).

  • Gold Standard: While often elusive, the definitive "gold standard" is the isolation of a pathogen from a sterile site, such as blood or pleural fluid culture (11). This provides a definitive microbiological diagnosis and antibiotic susceptibilities (the rationale), enabling the de-escalation of antibiotics to targeted therapy (the action) (22).

Monitoring & Staging

  • Full Blood Count (FBC): A baseline FBC is essential to look for neutrophilic leukocytosis, a common sign of bacterial infection, or leukopenia (the rationale), which is an ominous sign indicating overwhelming sepsis and a poor prognosis (the action) (2).

  • Renal Profile and Electrolytes: This is mandatory as a blood urea level >7 mmol/L is a core component of the CURB-65 score (the rationale). It is also vital for assessing renal function for drug dosing and detecting acute kidney injury from sepsis (the action) (8).

  • Inflammatory Markers (CRP/PCT): While C-reactive protein (CRP) is non-specific, it is almost always elevated in bacterial pneumonia (26). Procalcitonin (PCT), though not recommended to initiate antibiotics, can be valuable for monitoring response and guiding antibiotic de-escalation (40).

Management

Management Principles

The management of CAP is centered on three core principles: prompt and appropriate antibiotic therapy, maintenance of physiological stability through supportive care, and vigilant monitoring for complications (8, 54).

Acute Stabilisation (The First Hour)

  • Airway/Breathing: Administer supplemental oxygen to maintain SpO2 between 94-98% (or 88-92% for patients at risk of hypercapnic respiratory failure) (the action) to correct hypoxemia and prevent tissue hypoxia (the rationale) (8).

  • Circulation: Secure intravenous access. For patients with hypotension or signs of septic shock, begin rapid administration of 30 ml/kg of crystalloid fluid (the action) to restore tissue perfusion, a key component of the sepsis care bundle (the rationale) (41).

  • Disability: Formally assess for new confusion or altered mental status (the action), as this fulfills the 'C' criterion of the CURB-65 score and signifies severe illness requiring urgent escalation (the rationale) (8).

Definitive Therapy

Antibiotic choice is dictated by the Malaysian National Antimicrobial Guideline (NAG), stratified by severity.

  • First-Line Treatment (Moderate CAP, CURB-65 Score 2): The recommended regimen is IV Amoxicillin/clavulanate 1.2g q8h PLUS Azithromycin 500mg IV/PO q24h (8). This combination covers typical pathogens (S. pneumoniae, H. influenzae) with the beta-lactam and atypical pathogens with the macrolide, reflecting the local pathogen landscape (15, 68).

  • Second-Line/Escalation (Severe CAP, CURB-65 Score ≥3 or Pseudomonas risk): For severe CAP, the same combination is used (8). However, if risk factors for Pseudomonas aeruginosa are present (e.g., bronchiectasis, recent hospitalization with IV antibiotics), therapy should be escalated to an anti-pseudomonal agent like IV Piperacillin/tazobactam 4.5g q6-8h plus Azithromycin (8).

Supportive & Symptomatic Care

  • Analgesia: Provide regular paracetamol or other simple analgesics to manage pleuritic chest pain (the action), which improves comfort and facilitates effective coughing and deep breathing (the rationale) (54).

  • Antipyretics: Use paracetamol to control high fever (the action), thereby reducing metabolic demand and improving patient comfort (the rationale) (54).

  • VTE Prophylaxis: For all hospitalized patients with reduced mobility due to acute illness, administer prophylactic anticoagulation (e.g., LMWH) (the action) to prevent venous thromboembolism, a significant risk in this population (the rationale) (8).

Key Nursing & Monitoring Instructions

  • Monitor vital signs, including respiratory rate and SpO2, at least 4-hourly or more frequently if unstable.

  • Maintain a strict fluid balance chart (input/output).

  • Immediately escalate to the medical team for any of the following: systolic BP <90 mmHg, respiratory rate >30, SpO2 <92% on oxygen, new confusion, or urine output <0.5mL/kg/hr.

Long-Term Plan & Patient Education

Discharge planning is a critical phase focused on ensuring a safe recovery and preventing recurrence (88). A follow-up chest X-ray should be arranged for 6-8 weeks post-discharge, particularly for smokers, the elderly, or those with severe disease, to ensure radiological resolution and to exclude an underlying pathology like lung cancer (26). Patients must be educated on the importance of completing their full course of antibiotics, what to expect during recovery (persistent fatigue is common), and clear red flag symptoms that warrant immediate medical attention (88, 89). This is a vital opportunity to provide strong advice on smoking cessation and to recommend vaccination against S. pneumoniae and annual influenza (25).

When to Escalate

Call Your Senior (MO/Specialist) if:

  • The patient has a CURB-65 score of ≥ 3, indicating severe CAP (8).

  • The patient shows signs of impending or established respiratory failure (worsening hypoxemia, increasing work of breathing, exhaustion, or hypercapnia) (3).

  • The patient develops septic shock (persistent hypotension requiring vasopressors and elevated lactate despite fluid resuscitation) (41).

  • There is a failure to respond to appropriate antibiotic therapy within 48-72 hours, which may suggest a complication (e.g., empyema) or a resistant organism (82).

Referral Criteria:

  • Refer to the ICU team for any patient with severe CAP requiring invasive or non-invasive ventilation, or vasopressor support for septic shock (8).

  • Refer to the Cardiothoracic Surgery team for confirmed empyema or a complicated parapneumonic effusion that requires drainage via chest tube or video-assisted thoracoscopic surgery (VATS) (82, 84).


References

  1. Pneumonia - Community-Acquired: Disease Background | MIMS Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.mims.com/malaysia/disease/pneumonia-community-acquired/disease-background

  2. Clinical Practice Guidelines Management and Prevention of Adult Community Acquired Pneumonia - Philippine Society for Microbiology and Infectious Diseases. (n.d.). Retrieved July 8, 2025, from https://www.psmid.org/wp-content/uploads/2021/12/2020-Community-Acquired-Pneumonia-Clinical-Practice-Guidelines.pdf

  3. Community Acquired Pneumonia - A Malaysian Perspective - Medical Journal of Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.e-mjm.org/2005/v60n2/Community_Acquired_Pneumonia.pdf

  4. What is pneumonia? Here's everything you need to know about Malaysia's top killer in 2023. (2024, November 4). Malay Mail. Retrieved July 8, 2025, from https://www.malaymail.com/news/malaysia/2024/11/04/what-is-pneumonia-heres-everything-you-need-to-know-about-malaysias-top-killer-in-2023/155603

  5. Community-acquired pneumonia: An Asia Pacific perspective - PMC - PubMed Central. (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC7169174/

  6. OPA14 PREVALENCE AND CLINICAL OUTCOMES OF VIRAL PNEUMONIA IN THE MALAYSIAN ADULT URBAN POPULATION - MTS Congress 2024. (n.d.). Retrieved July 8, 2025, from https://2024.mts.org.my/pages/default/158203

  7. Streptococcus pneumoniae Isolates in Malaysia - Science Open. (n.d.). Retrieved July 8, 2025, from https://www.scienceopen.com/document_file/7a79e08e-8834-47cd-a6bd-3f339299f15c/PubMedCentral/7a79e08e-8834-47cd-a6bd-3f339299f15c.pdf

  8. Pneumonia - Community-Acquired: Management | MIMS Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.mims.com/malaysia/disease/pneumonia-community-acquired/management

  9. National Antimicrobial Guideline (NAG), Ministry of Health Malaysia - A11: RESPIRATORY INFECTIONS. (n.d.). Google Sites. Retrieved July 8, 2025, from https://sites.google.com/moh.gov.my/nag/contents/section-a-adult/a11-respiratory-infections

  10. Pneumonia 101: Symptoms, Causes, Treatment & Stages - Homage... (n.d.). Retrieved July 8, 2025, from https://www.homage.com.my/health/pneumonia/

  11. Community-Acquired Pneumonia (CAP) - Medscape Reference. (n.d.). Retrieved July 8, 2025, from https://emedicine.medscape.com/article/234240-overview

  12. (PDF) Community acquired pneumonia - A Malaysian perspective - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/7646931_Community_acquired_pneumonia_A_Malaysian_perspective

  13. ORIGINAL ARTICLE Preliminary Assessment of Adherence to ... (n.d.). Retrieved July 8, 2025, from https://www.ajmhsrcmp.org/images/journal/Vol7_Issue1_June24/07_NazmiLiana_AJMHS_2024_Vol7_Issue1_OriginalArticle_CURB65.pdf

  14. Community-Acquired Pneumonia in the Asia-Pacific Region - Thieme Connect. (n.d.). Retrieved July 8, 2025, from https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0036-1592075.pdf

  15. (PDF) Community acquired pneumonia in Malaysia: Is... (n.d.). ResearchGate. Retrieved July 8, 2025, from https://www.researchgate.net/publication/278139909_Community_acquired_pneumonia_in_Malaysia_Is_Streptococcus_pneumoniae_an_important_pathogen

  16. Viral non-SARS-CoV-2 etiology of community-acquired pneumonia (CAP) in Southeast Asia: a review and pooled analysis - PubMed Central. (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC12205657/

  17. Pneumonia now the leading cause of certified deaths in Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.sunwaymedicalvelocity.com.my/en/blogs/pneumonia-now-the-leading-cause-of-certified-deaths-in-malaysia/

  18. National Antimicrobial Guideline (NAG), Ministry of Health Malaysia - B10: RESPIRATORY INFECTIONS - Google Sites. (n.d.). Retrieved July 8, 2025, from https://sites.google.com/moh.gov.my/nag/contents/section-b-paediatrics/b10-respiratory-infections

  19. Respiratory History Taking - OSCE Guide | Geeky Medics. (n.d.). Retrieved July 8, 2025, from https://geekymedics.com/respiratory-history-taking/

  20. Respiratory exam - OSCE - SimpleOSCE. (n.d.). Retrieved July 8, 2025, from https://simpleosce.com/examinations/core/respiratory-examination.html

  21. Respiratory Examination - OSCE Guide | Geeky Medics. (n.d.). Retrieved July 8, 2025, from https://geekymedics.com/respiratory-examination-2/

  22. Practice OSCE station | Pneumonia. (n.d.). Retrieved July 8, 2025, from https://www.oscesense.com/osce-practice-medicine-respiratory-pneumonia

  23. OSCE Pneumonia Patient Instructions. (n.d.). Retrieved July 8, 2025, from https://nonpf.confex.com/nonpf/2015md/webprogram/Handout/Session4152/OSCE%20case_chart_checklist_survey%20PNEUMONIA.pdf

  24. OSCE: Respiratory History and Examination | PDF | Cough | Chronic Obstructive Pulmonary Disease - Scribd. (n.d.). Retrieved July 8, 2025, from https://www.scribd.com/document/289818953/OSCE-Respiratory-History-and-Examination

  25. Pneumonia: Missing The Signs - Immunise4Life | The Malaysian Medical Gazette. (n.d.). Retrieved July 8, 2025, from https://www.mmgazette.com/pneumonia-missing-the-signs-immunise4life/

  26. Clinical Practice Guidelines: Community acquired pneumonia. (n.d.). Retrieved July 8, 2025, from https://www.rch.org.au/clinicalguide/guideline_index/Community_acquired_pneumonia/

  27. Bronchitis and Pneumonia - PMC - PubMed Central. (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC7348617/

  28. Bronchitis and Pneumonia - California Childcare Health Program - UCSF. (n.d.). Retrieved July 8, 2025, from https://cchp.ucsf.edu/resources/fact-sheets-families/bronchitis-and-pneumonia

  29. Is It Bronchitis Or Pneumonia? - Franciscan Health. (n.d.). Retrieved July 8, 2025, from https://www.franciscanhealth.org/community/blog/bronchitis-vs-pneumonia

  30. Bronchitis vs. Pneumonia: What is The Difference? | Orlando - UCF Health. (n.d.). Retrieved July 8, 2025, from https://ucfhealth.com/our-services/primary-care/bronchitis-vs-pneumonia/

  31. Bronchitis vs. Pneumonia: Telling the Difference - Healthline. (n.d.). Retrieved July 8, 2025, from https://www.healthline.com/health/bronchitis-vs-pneumonia

  32. Bronchitis vs. Pneumonia: How To Tell the Difference - Health Cleveland Clinic. (n.d.). Retrieved July 8, 2025, from https://health.clevelandclinic.org/bronchitis-vs-pneumonia

  33. Pulmonary Embolism > Fact Sheets > Yale Medicine. (n.d.). Retrieved July 8, 2025, from https://www.yalemedicine.org/conditions/pulmonary-embolism

  34. Pulmonary embolism - Symptoms and causes - Mayo Clinic. (n.d.). Retrieved July 8, 2025, from https://www.mayoclinic.org/diseases-conditions/pulmonary-embolism/symptoms-causes/syc-20354647

  35. Atypical Presentation of Pneumonia Mimicking Pulmonary Embolism - Aditum Publication. (n.d.). Retrieved July 8, 2025, from https://aditum.org/journals/%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20international-journal-of-medical-case-reports-and-medical-research/current-issue/991

  36. Initial symptoms in pulmonary embolism differ from those in pneumonia: A retrospective study during seven years (European Journal of Emergency Medicine (2006) 13, (225-229)) - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/289877129_Initial_symptoms_in_pulmonary_embolism_differ_from_those_in_pneumonia_A_retrospective_study_during_seven_years_European_Journal_of_Emergency_Medicine_2006_13_225-229

  37. What are the symptoms of PE? - National Blood Clot Alliance. (n.d.). Retrieved July 8, 2025, from https://www.stoptheclot.org/diagnosis_symptoms/what_are_symptoms_of_pe/

  38. Current Thinking in Acute Congestive Heart Failure and Pulmonary Edema | USC Journal. (n.d.). Retrieved July 8, 2025, from https://www.uscjournal.com/articles/current-thinking-acute-congestive-heart-failure-and-pulmonary-edema-0

  39. Current Thinking in Acute Congestive Heart Failure and Pulmonary ... (n.d.). Retrieved July 8, 2025, from https://www.uscjournal.com/articles/current-thinking-acute-congestive-heart-failure-and-pulmonary-edema-0

  40. Guide to Antimicrobial Therapy 2023 Cover - Malaysian Society of Intensive Care. (n.d.). Retrieved July 8, 2025, from https://www.msic.org.my/wp-content/uploads/2024/05/Guide-to-Antimicrobial-Therapy-2023-4.pdf

  41. Surviving Sepsis Campaign Guidelines 2021 | SCCM - Society of Critical Care Medicine. (n.d.). Retrieved July 8, 2025, from https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-guidelines-2021

  42. Pneumonia - Hospital-Acquired: Management | MIMS Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.mims.com/malaysia/disease/pneumonia-hospital-acquired/management

  43. Pneumonia | Lung inflammation - Diagnosis, Evaluation and Treatment - Radiologyinfo.org. (n.d.). Retrieved July 8, 2025, from https://www.radiologyinfo.org/en/info/pneumonia

  44. Chest X-Ray For Pneumonia: Diagnosis And Interpretation - One Step Diagnostic. (n.d.). Retrieved July 8, 2025, from https://onestepdiagnostic.com/chest-x-ray-for-pneumonia-diagnosis/

  45. Chest X-ray Interpretation | A Structured Approach | Radiology | OSCE - Geeky Medics. (n.d.). Retrieved July 8, 2025, from https://geekymedics.com/chest-x-ray-interpretation-a-methodical-approach/

  46. Chest X-Ray - Lung disease - The Radiology Assistant. (n.d.). Retrieved July 8, 2025, from https://radiologyassistant.nl/chest/chest-x-ray/lung-disease

  47. X-ray Atlas: Chest X-ray | GLOWM. (n.d.). Retrieved July 8, 2025, from https://www.glowm.com/atlas-page/atlasid/chestXray.html

  48. Chest X-Ray - Basic Interpretation - The Radiology Assistant. (n.d.). Retrieved July 8, 2025, from https://radiologyassistant.nl/chest/chest-x-ray/basic-interpretation

  49. CURB-65 Score for Pneumonia Severity - MDCalc. (n.d.). Retrieved July 8, 2025, from https://www.mdcalc.com/calc/324/curb-65-score-pneumonia-severity

  50. (PDF) Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/43019674_Validity_of_pneumonia_severity_index_and_CURB-65_severity_scoring_systems_in_community_acquired_pneumonia_in_an_Indian_setting

  51. (PDF) Prognostic values of pneumonia severity index, CURB-65 and expanded CURB-65 scores in community-acquired pneumonia in Zagazig University Hospitals - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/312647550_Prognostic_values_of_pneumonia_severity_index_CURB-65_and_expanded_CURB-65_scores_in_community-acquired_pneumonia_in_Zagazig_University_Hospitals

  52. CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting | Request PDF - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/229160469_CURB-65_score_predicted_mortality_in_community-acquired_pneumonia_better_than_IDSAATS_minor_criteria_in_a_low-mortality-rate_setting

  53. ejournal.unikl.edu.my. (n.d.). Retrieved July 8, 2025, from https://ejournal.unikl.edu.my/index.php/ajmhs/citationstylelanguage/get/harvard-cite-them-right?submissionId=202&publicationId=202&issueId=14

  54. Bacterial Pneumonia Treatment & Management: Approach... (n.d.). Medscape. Retrieved July 8, 2025, from https://emedicine.medscape.com/article/300157-treatment

  55. National Antimicrobial Guideline (NAG) 2024, 4th Edition - Pharmacy.gov.my. (n.d.). Retrieved July 8, 2025, from https://pharmacy.moh.gov.my/en/documents/national-antimicrobial-guideline-nag-2024-4th-edition.html

  56. National Antimicrobial Guideline (NAG), Ministry of Health Malaysia - CONTENTS. (n.d.). Google Sites. Retrieved July 8, 2025, from https://sites.google.com/moh.gov.my/nag/contents

  57. National Antimicrobial Guideline (NAG), Ministry of Health Malaysia - Google Sites. (n.d.). Retrieved July 8, 2025, from https://sites.google.com/moh.gov.my/nag

  58. Adherence to National Antimicrobial Guidelines in Hospitalized Geriatric Patients with Community-Acquired Pneumonia: A Prospective Observational study in a Malaysian Hospital - PMC. (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC8698928/

  59. Full article: Impact evaluation of guidelines on antibiotic utilisation & appropriateness in Malaysian public primary care: an interrupted time series analysis. (n.d.). Retrieved July 8, 2025, from https://www.tandfonline.com/doi/full/10.1080/20523211.2024.2355666

  60. Malaysian Action Plan on Antimicrobial Resistance (MyAP-AMR) - World Health Organization (WHO). (n.d.). Retrieved July 8, 2025, from https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/malaysia-amr-nap-2022-2026.pdf?sfvrsn=f5fd5df4_3&download=true

  61. Pneumonia Malaysia - symptoms, causes, and treatments available in Kuala Lumpur | Dr. Nurul Yaqeen. (n.d.). Retrieved July 8, 2025, from https://chestspecialistmalaysia.com/pneumonia-malaysia-symptoms-causes-treatment-kuala-lumpur/

  62. Malaysian Action Plan on Antimicrobial Resistance (MyAP-AMR) 2017-2021. (n.d.). Retrieved July 8, 2025, from https://www.moh.gov.my/moh/resources/Penerbitan/Garis%20Panduan/Pengurusan%20KEsihatan%20&%20kawalan%20pykit/Malaysian_Action_Plan_on_Antimicrobial_Resistance_(MyAP-AMR)_2017-2021.pdf

  63. Malaysian Action Plan - FAOLEX Database | Food and Agriculture Organization of the United Nations. (n.d.). Retrieved July 8, 2025, from https://faolex.fao.org/docs/pdf/mal227142.pdf

  64. Wrong treatment of sore throats is fuelling antimicrobial resistance | The Star. (n.d.). Retrieved July 8, 2025, from https://www.thestar.com.my/lifestyle/health/2025/07/02/wrong-treatment-of-sore-throats-is-fuelling-antimicrobial-resistance

  65. Malaysia | GHS Index. (n.d.). Retrieved July 8, 2025, from https://ghsindex.org/wp-content/uploads/2021/12/Malaysia.pdf

  66. The burden of antimicrobial resistance (AMR) in Malaysia - Institute for Health Metrics and Evaluation. (n.d.). Retrieved July 8, 2025, from https://www.healthdata.org/sites/default/files/2023-09/Malaysia.pdf

  67. Prevalence of Antibiotic-Resistant Pathogenic Bacteria and Level of Antibiotic Residues in Hospital Effluents in Selangor, Malaysia: Protocol for a Cross-sectional Study. (n.d.). Retrieved July 8, 2025, from https://www.researchprotocols.org/2023/1/e39022

  68. Detection of Macrolide-Resistant Streptococcus pneumoniae Genes ... (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC11057836/

  69. Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia | PLOS One. (n.d.). Retrieved July 8, 2025, from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0019547

  70. Antibiotic susceptibility profile of Haemophilus influenzae and transfer of co-trimoxazole resistance determinants - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/231224751_Antibiotic_susceptibility_profile_of_Haemophilus_influenzae_and_transfer_of_co-trimoxazole_resistance_determinants

  71. Serotypes and beta-lactamase-producing Haemophilus influenzae isolated from children attending childcare centres in Kuala Lumpur post vaccination era - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/348642349_Serotypes_and_beta-lactamase-producing_Haemophilus_influenzae_isolated_from_children_attending_childcare_centres_in_Kuala_Lumpur_post_vaccination_era

  72. Antimicrobial Susceptibility Patterns of Haemophilus influenzae and Streptococcus pneumoniae in Respiratory Tract Infections: A - JCDR. (n.d.). Retrieved July 8, 2025, from https://jcdr.net/articles/PDF/20677/75929_CE[Ra1]_F(KR)_QC(AN_IS)_PF1(AG_SL)_PFA(IS)_PB(AG_IS)_PN(IS).pdf

  73. -Lactam Resistance in Upper Respiratory Tract Pathogens Isolated from a Tertiary Hospital in Malaysia - PMC. (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC8705930/

  74. SURVEILLANCE OF ANTIMICROBIAL SUSCEPTIBILITY. (n.d.). Retrieved July 8, 2025, from https://wiredspace.wits.ac.za/server/api/core/bitstreams/22c3ae56-3c90-45b7-8c7b-819a3848f459/content

  75. Trends in antimicrobial resistance in Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.e-mjm.org/2021/v76n5/antimicrobial-resistance.pdf

  76. (PDF) Incidence of Klebsiella pneumonia in street foods sold in Malaysia and their characterization by antibiotic resistance, plasmid profiling, and RAPD-PCR analysis - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/222692158_Incidence_of_Klebsiella_pneumonia_in_street_foods_sold_in_Malaysia_and_their_characterization_by_antibiotic_resistance_plasmid_profiling_and_RAPD-PCR_analysis

  77. Pneumonia - Hospital-Acquired: Disease Summary | MIMS Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.mims.com/malaysia/disease/pneumonia-hospital-acquired/disease-summary

  78. Sepsis management: a quick guide (suitable for low-middle income countries) | Request PDF - ResearchGate. (n.d.). Retrieved July 8, 2025, from https://www.researchgate.net/publication/338374715_Sepsis_management_a_quick_guide_suitable_for_low-middle_income_countries

  79. Sepsis Management: A Quick Guide - Dr Tan Toh Leong, Dr Lim... (n.d.). Retrieved July 8, 2025, from https://books.google.com/books/about/Sepsis_Management_A_Quick_Guide.html?id=rvSiDwAAQBAJ

  80. Ebook "Sepsis Management: A Quick Guide" updated year 2023. (n.d.). Retrieved July 8, 2025, from https://mysepsis.blogspot.com/2019/08/ebook-sepsis-management-quick-guide.html

  81. Malaysian Sepsis Alliance. (n.d.). Retrieved July 8, 2025, from https://mysepsis.blogspot.com/

  82. Diagnosis and Management of Parapneumonic Effusions and Empyema | Clinical Infectious Diseases | Oxford Academic. (n.d.). Retrieved July 8, 2025, from https://academic.oup.com/cid/article/45/11/1480/334422

  83. Parapneumonic Pleural Effusions and Empyema Thoracis - StatPearls - NCBI Bookshelf. (n.d.). Retrieved July 8, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK534297/

  84. Empyema and Parapneumonic Effusions: General Considerations ... (n.d.). Retrieved July 8, 2025, from https://gme.medicine.uiowa.edu/iowaprotocols/empyema-and-parapneumonic-effusions-general-considerations

  85. Diagnosis and management of pleural infection | European Respiratory Society. (n.d.). Retrieved July 8, 2025, from https://publications.ersnet.org/content/breathe/19/4/230146

  86. British Thoracic Society Guideline for pleural disease - Thorax. (n.d.). Retrieved July 8, 2025, from https://thorax.bmj.com/content/78/11/1143

  87. Emergent Management of Empyema - PMC. (n.d.). Retrieved July 8, 2025, from https://pmc.ncbi.nlm.nih.gov/articles/PMC3577590/

  88. Adult Pneumonia Patient Information Leaflet :: Frimley Healthier Together. (n.d.). Retrieved July 8, 2025, from https://frimley-healthiertogether.nhs.uk/professionals/safety-netting-documents-parents/adult-safety-netting/pneumonia-patient-information-leaflet

  89. Pneumonia: Symptoms, Causes, and Treatment - Patient.info. (n.d.). Retrieved July 8, 2025, from https://patient.info/chest-lungs/chest-infection/pneumonia

  90. Pneumonia in Older Adults: Causes, Symptoms, and Prevention - Homage Malaysia. (n.d.). Retrieved July 8, 2025, from https://www.homage.com.my/health/older-adults-pneumonia/

  91. Pneumococcal Pneumonia - Risks and Prevention Info | Prevent Pneumonia. (n.d.). Retrieved July 8, 2025, from https://preventpneumonia.com.my/

  92. Pneumonia in Older People - Pantai Hospitals. (n.d.). Retrieved July 8, 2025, from https://www.pantai.com.my/health-pulse/pneumonia-older-people

  93. World Pneumonia Day - The Malaysian Paediatric Association. (n.d.). Retrieved July 8, 2025, from https://mpaeds.my/wp-content/uploads/2021/05/BMPA-4-2020-NOV_web.pdf

Previous
Previous

Hemorrhagic Stroke

Next
Next

Acute Coronary Syndrome (ACS)